Teclistamab Shows 'Promising' Activity in R/R Multiple Myeloma
Investigational drug teclistamab is 'a promising new, off-the-shelf, T-cell redirecting therapy targeting BCMA for patients with relapsed or refractory MM,' say researchers.
Medscape Medical News
source https://www.medscape.com/viewarticle/975071?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/975071?src=rss
Comments
Post a Comment